Often dreaming of new pharmaceutical solutions in his sleep, Dr. Yun K. Tam, developed Pharmaceutical Platform Technology (PPT®) in 2006. This patented scientific lab research process is essential for the discovery of key ingredients responsible for effective medicines using the principles of molecular pharmacology, analytical chemistry, computational and mechanical engineering. This system of processes allows production of recipes with defined actives that bridge the gap between holistic medicines and multi-target pharmaceutical grade botanical medicines. Precise recipes of medicinal compounds can be developed into products that are designed to absorb seamlessly and consistently in the human body. With PPT® we create medicines that synergistically pack purity and potency to be highly effective, safe, consistent, and reliable batch after batch. Customers can now access ancient remedies made of precise medicinal ingredients that are consistent in every single dose.



In Silico – Computational Research

Our computational team specializes in theoretical physics, computational fluid dynamics, information theory, computational biology, bioinformatics and systems biology. In addition to these specialties, we also have access to Pharmamatrix, the high-performance computing facility from University of Alberta and various licensed software for developing herbal medicines. The team plays an integral part in improving and executing PPT® strategies. A number of tools, methodologies in chemical and network mining and analysis, and information-driven efficacy prediction have been developed.

As the control unit of PPT®, the In Silico Division collects, manages, and analyzes all outside and inhouse research data to drive research and development. Given this platform, we can now predict and optimize the efficacy and drug-like properties: absorption, distribution, metabolism, excretion, and toxicity of herbal ingredients and metabolites within the human body. The result is a highly efficacious and safe herbal recipe.

In Vitro – Molecular Pharmacology Lab Research

Our brilliant research team of pharmacists, molecular biologists, and chemists understand that not all chemicals are good drugs. The team develops in-vitro cell-based models for screening plant extracts prepared by SinoVeda’s analytical chemistry division. Using state of the art organoid-based disease models to better represent physiologic conditions, this team also performs cell based in-vitro pharmacokinetic analysis of lead compounds and extracts, and high throughput Polymerase Chain Reaction (PCR) genetic screening and uses immuno-fluorescence analytical techniques.

Using PPT® coupled with recent molecular and cell biology techniques and compounds identification, we can test the outcome potential of medications. With this methodology we can bring new medicines to market faster by testing on organoids, an artificially grown mass of cells or tissue that resembles a human organ.


Pharmaceutical Pipeline Currently in Development

SinoVeda Canada Inc. Technology


  • A candidate for treating vaginal atrophy
  • Stage of Development: Preparation for Investigational New Drug (IND)
Treat Osteoporosis


  • A candidate for treating osteoporosis
  • Stage of Development: Preclinical
Treat Type 2 Diabetes


  • A candidate for treating type II diabetes
  • Stage of Development: Preclinical
Treat Artemisinin Resistant Malaria


  • A candidate for treating artemisinin resistant malaria
  • Stage of Development: Preclinical
Treat Neurodegenerative Disease


  • Formulas consisting of cannabis for treating pain and neurodegenerative diseases
  • Stage of Development: Preclinical